Enhanced EGFR inhibition and distinct epitope recognition by EGFR antagonistic mAbs C225 and 425

Cancer Biology & Therapy
Vishal KamatUlrich Rodeck

Abstract

Monoclonal antibodies (mAbs) that inhibit activation of the epidermal growth factor receptor (EGFR) have shown therapeutic potential in select malignancies including breast cancer. Here, we describe that combined use of two such mAbs, C225 (Cetuximab) and 425 (EMD55900), reduced growth and survival of EGFR overexpressing MDA-MB-468 breast cancer cells more effectively than either antibody alone. Similarly, the C225/425 antibody combination more effectively inhibited AKT and MAPK phosphorylation in MDA-MB-468 cells. Surface plasmon resonance, size exclusion chromatography and analytical ultracentrifugation demonstrated that mAbs C225 and 425 simultaneously bind to distinct antigenic epitopes on domain III of the soluble wild-type EGFR. Furthermore, neither mAb competed with the other for binding to cells expressing either wild-type EGFR or a mutant EGFR (EGFRvIII) associated with neoplasia. Mutagenesis experiments revealed that residues S460/G461 in EGFR domain III are essential components of the 425 epitope and clearly distinguish it from the EGF/ TGFalpha binding site and the C225 interaction interface. Collectively, these results support the conclusion that therapeutic EGFR blockade in cancer patients by combined use of mAbs ...Continue Reading

Citations

May 8, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Florian KampmeierTheo Thepen
Jun 5, 2013·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Mohammed Salman ShazeebAlexei Bogdanov
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jamie B SpanglerK Dane Wittrup
Oct 9, 2013·Proceedings of the National Academy of Sciences of the United States of America·Joshua M DonaldsonJohn C Williams
Jan 27, 2012·DNA and Cell Biology·Kobra Omidfar, Zaynab Shirvani
Jan 12, 2011·Biochemical and Biophysical Research Communications·Akinori HisatsuneHiroshi Katsuki
Nov 11, 2008·Experimental Cell Research·Karl R Schmitz, Kathryn M Ferguson
Apr 27, 2011·International Journal of Cancer. Journal International Du Cancer·Rob C RooversPaul M P van Bergen en Henegouwen
Dec 18, 2009·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka
Dec 1, 2014·Journal of Cancer Research and Clinical Oncology·Judith NiesenStefan Barth
Feb 14, 2012·MAbs·Eugen Dhimolea, Janice M Reichert
Jun 24, 2011·MAbs·Stephen J DemarestJianying Dong
Jan 27, 2017·Journal of Immunotherapy·Gennaro RiccioClaudia De Lorenzo
May 24, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kevin Chu FoyPravin T P Kaumaya
Aug 16, 2016·Targeted Oncology·Radoslaw KwapiszewskiKarolina Adamkiewicz
Jun 26, 2021·Radiology. Imaging Cancer·Tobias BäuerleAlexei Bogdanov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.